British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has unveiled plans to double its investment in Egypt in the next three year, reports say.
Hatem Werdany, Director of the company in the Arab Republic, has indicated that the multinational has invested over EGP 1 billion ($60 million) since entering the Egyptian market in 2006.
Werdany also indicated that the company seeks to take part in supporting the local healthcare sector as Egypt is one of the main regional and global markets for AstraZeneca, reports note.
AstraZeneca Egypt produces 900 million tablets per annum.
The company in 2021 reportedly recorded sales of EGP 1.92 billion, with a growth rate of 15.8%.
AstraZeneca to double investment in Egypt over next three years
